These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 7997881)
1. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Thibodeau J; Cloutier I; Lavoie PM; Labrecque N; Mourad W; Jardetzky T; Sékaly RP Science; 1994 Dec; 266(5192):1874-8. PubMed ID: 7997881 [TBL] [Abstract][Full Text] [Related]
2. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Kim J; Urban RG; Strominger JL; Wiley DC Science; 1994 Dec; 266(5192):1870-4. PubMed ID: 7997880 [TBL] [Abstract][Full Text] [Related]
3. Molecular docking of superantigens with class II major histocompatibility complex proteins. Olson MA; Cuff L J Mol Recognit; 1997; 10(6):277-89. PubMed ID: 9770652 [TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1. von Bonin A; Ehrlich S; Malcherek G; Fleischer B Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089 [TBL] [Abstract][Full Text] [Related]
5. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens. Labrecque N; Thibodeau J; Mourad W; Sékaly RP J Exp Med; 1994 Nov; 180(5):1921-9. PubMed ID: 7964467 [TBL] [Abstract][Full Text] [Related]
6. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens. Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029 [TBL] [Abstract][Full Text] [Related]
7. Altered orientation of streptococcal superantigen (SSA) on HLA-DR1 allows unconventional regions to contribute to SSA Vbeta specificity. Stevens KR; Van M; Lamphear JG; Rich RR J Immunol; 1996 Dec; 157(11):4970-8. PubMed ID: 8943403 [TBL] [Abstract][Full Text] [Related]
9. Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM. Lavoie PM; Thibodeau J; Cloutier I; Busch R; Sékaly RP Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6892-7. PubMed ID: 9192662 [TBL] [Abstract][Full Text] [Related]
10. Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules. Thibodeau J; Labrecque N; Denis F; Huber BT; Sékaly RP J Exp Med; 1994 Mar; 179(3):1029-34. PubMed ID: 8113671 [TBL] [Abstract][Full Text] [Related]
11. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2. Fernández MM; Bhattacharya S; De Marzi MC; Brown PH; Kerzic M; Schuck P; Mariuzza RA; Malchiodi EL Proteins; 2007 Jul; 68(1):389-402. PubMed ID: 17427250 [TBL] [Abstract][Full Text] [Related]
12. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E. Karp DR; Long EO J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684 [TBL] [Abstract][Full Text] [Related]
13. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II. Hudson KR; Tiedemann RE; Urban RG; Lowe SC; Strominger JL; Fraser JD J Exp Med; 1995 Sep; 182(3):711-20. PubMed ID: 7650479 [TBL] [Abstract][Full Text] [Related]
14. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells. Hogan RJ; VanBeek J; Broussard DR; Surman SL; Woodland DL J Immunol; 2001 Jun; 166(11):6514-22. PubMed ID: 11359802 [TBL] [Abstract][Full Text] [Related]
15. Staphylococcal toxins bind to different sites on HLA-DR. Chintagumpala MM; Mollick JA; Rich RR J Immunol; 1991 Dec; 147(11):3876-81. PubMed ID: 1940373 [TBL] [Abstract][Full Text] [Related]
16. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules. Scholl PR; Diez A; Geha RS J Immunol; 1989 Oct; 143(8):2583-8. PubMed ID: 2551962 [TBL] [Abstract][Full Text] [Related]
17. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1. Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008 [TBL] [Abstract][Full Text] [Related]
18. Multiple binding sites on the superantigen, staphylococcal enterotoxin B, imparts versatility in binding to MHC class II molecules. Soos JM; Johnson HM Biochem Biophys Res Commun; 1994 Jun; 201(2):596-602. PubMed ID: 8002991 [TBL] [Abstract][Full Text] [Related]
19. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules. Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498 [TBL] [Abstract][Full Text] [Related]
20. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules. Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]